Literature DB >> 34909869

PCR performance in the SARS-CoV-2 Omicron variant of concern?

César M J A Metzger1, Reto Lienhard2,3, Helena M B Seth-Smith4,5, Tim Roloff4,5, Fanny Wegner5, Jonas Sieber1, Michael Bel6, Gilbert Greub3,7, Adrian Egli3,4,5.   

Abstract

The new SARS-CoV-2 Omicron variant (B.1.1.529) has been recently declared a Variant of Concern due to a series of important mutations in the viral spike protein and especially in the receptor-binding domain. While investigations into the spread of this new variant are ongoing, the first cases have been detected in Switzerland. Important questions have been raised: (1) Will the PCR assays commonly used to detect SARS-CoV-2 still work for the Omicron variant? (2) Can specific PCR features, e.g. S-gene dropout, be used to identify potential Omicron samples? In this minireview we provide current knowledge on the Omicron variant and guidance on its PCR validation.

Entities:  

Mesh:

Year:  2021        PMID: 34909869     DOI: 10.4414/smw.2021.w30120

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  20 in total

1.  Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; África Holguín
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  SARS-CoV-2: phenotype, genotype, and characterization of different variants.

Authors:  Mohammadreza Saberiyan; Elham Karimi; Zahra Khademi; Parvaneh Movahhed; Amir Safi; Ameneh Mehri-Ghahfarrokhi
Journal:  Cell Mol Biol Lett       Date:  2022-06-17       Impact factor: 8.702

3.  Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron.

Authors:  Justin Hardick; Nicholas Gallagher; Andrew Pekosz; Yukari C Manabe; Heba H Mostafa; Jaiprasath Sachithanandham; Amary Fall; Zishan Siddiqui
Journal:  Microbiol Spectr       Date:  2022-05-26

Review 4.  Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Authors:  Stephani C Wang; Fengmin Zhang; Hui Zhu; Haipeng Yang; Yang Liu; Ping Wang; Vladimir Parpura; Yu-Feng Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

Review 5.  Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection.

Authors:  Endeshaw Chekol Abebe; Markeshaw Tiruneh G/Medhin; Awgichew Behaile T/Mariam; Tadesse Asmamaw Dejenie; Teklie Mengie Ayele; Fitalew Tadele Admasu; Zelalem Tilahun Muche; Getachew Asmare Adela
Journal:  Infect Drug Resist       Date:  2022-04-15       Impact factor: 4.177

Review 6.  Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Authors:  William R Strohl; Zhiqiang Ku; Zhiqiang An; Stephen F Carroll; Bruce A Keyt; Lila M Strohl
Journal:  BioDrugs       Date:  2022-04-27       Impact factor: 7.744

7.  Unusual N Gene Dropout and Ct Value Shift in Commercial Multiplex PCR Assays Caused by Mutated SARS-CoV-2 Strain.

Authors:  Petros Bozidis; Eleni T Tsaousi; Charilaos Kostoulas; Prodromos Sakaloglou; Athanasia Gouni; Despoina Koumpouli; Hercules Sakkas; Ioannis Georgiou; Konstantina Gartzonika
Journal:  Diagnostics (Basel)       Date:  2022-04-13

Review 8.  Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.

Authors:  Vineet Sharma; Himanshu Rai; Dev N S Gautam; Pradeep K Prajapati; Rohit Sharma
Journal:  J Med Virol       Date:  2022-02-03       Impact factor: 20.693

Review 9.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

10.  Application experience of a rapid nucleic acid detection system for COVID-19.

Authors:  Qing Ye; Dezhao Lu; Ting Zhang; Jianhua Mao; Shiqiang Shang
Journal:  Microbes Infect       Date:  2022-01-31       Impact factor: 9.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.